ALEXION PHARMACEUTICALS, INC. STOCK OPTION AGREEMENT2004 Incentive Plan • February 23rd, 2009 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS AGREEMENT, made as of this day of , (the “Grant Date”), by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and you (the “Optionee”) sets forth the terms and conditions of an Award granted to the Optionee under the Alexion Pharmaceuticals, Inc. 2004 Incentive Plan (the “Plan”).
ALEXION PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT AGREEMENT FOR FRENCH PARTICIPANTSRestricted Stock Unit Agreement • February 23rd, 2009 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS AGREEMENT, made as of this day of , 200 (the “Grant Date”), by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and you (“Participant”) sets forth the terms and conditions of an Award of restricted stock units (“Restricted Stock Units”) granted to Participant under the Alexion Pharmaceuticals, Inc. 2004 Incentive Plan and the Rules of the Alexion Pharmaceuticals, Inc. Amended and Restated 2004 Incentive Plan for Awards Granted to Participants in France (the “French Plan”) (collectively, the “Plan”).
ALEXION PHARMACEUTICALS, INC. STOCK OPTION AGREEMENT FOR PARTICIPANTS IN FRANCE2004 Incentive Plan • February 23rd, 2009 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS AGREEMENT, made as of this day of , (the “Grant Date”), by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and you (the “Optionee”) sets forth the terms and conditions of an Award granted to the Optionee under the Alexion Pharmaceuticals, Inc. 2004 Incentive Plan (the “U.S. Plan”) and the Rules of the Alexion Pharmaceuticals, Inc. Amended and Restated 2004 Incentive Plan for Awards Granted to Participants in France (the “French Plan”) (collectively, the “Plan”).
ALEXION PHARMACEUTICALS, INC. RESTRICTED STOCK AWARD AGREEMENTRestricted Stock Award Agreement • February 23rd, 2009 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS AGREEMENT, made as of this day of , 200 (the “Grant Date”), by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and you (“Participant”) sets forth the terms and conditions of an Award of Restricted Stock granted to Participant under the Alexion Pharmaceuticals, Inc. 2004 Incentive Plan (the “Plan”).
SETTLEMENT AGREEMENT dated December 31, 2008 between PDL BIOPHARMA, INC., and ALEXION PHARMACEUTICALS, INC.Settlement Agreement • February 23rd, 2009 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Settlement Agreement is entered into effective December 31, 2008 (“Effective Date”) between PDL BioPharma, Inc., a corporation organized under the laws of the State of Delaware, and Alexion Pharmaceuticals, Inc., a corporation organized under the laws of the State of Delaware.
PATENT LICENSE AGREEMENT dated December 31, 2008 between PDL BIOPHARMA, INC. and ALEXION PHARMACEUTICALS, INC.Patent License Agreement • February 23rd, 2009 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Patent License Agreement (this “Agreement”), effective as of December 31, 2008 (“Effective Date”), is made by and between PDL BioPharma, Inc., a Delaware corporation having offices at 932 Southwood Boulevard, Incline Village, NV 89451 (“PDL”), and Alexion Pharmaceuticals, Inc., a Delaware corporation having offices at 352 Knotter Drive, Cheshire, CT 06410 (“Alexion”).
AMENDMENT No. 13 to the Large Scale Product Supply Agreement dated 18 December 2002 between LONZA SALES AG and ALEXION INTERNATIONAL S.A.R.L. Additional Batches of Eculizumab Product in 2009 through 2013Alexion Pharmaceuticals Inc • February 23rd, 2009 • Pharmaceutical preparations
[*] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission.
